Resilience and ART Adherence Among a Sample of Racially and Ethnically Diverse Sexual Minority Men With HIV
Open Access
- 1 January 2025
- journal article
- Published by Wiley in AIDS Research and Treatment
- Vol. 2025 (1)
Abstract
While racial disparities in HIV antiretroviral treatment (ART) adherence and viral suppression among sexual minority men (SMM) with HIV persist, resilience may serve as an important protective factor. There is, however, a dearth of research exploring the longitudinal associations between resilience and ART adherence among this group. As such, the current study examined prospective associations, including the between‐ and within‐person effects, between resilience and ART adherence among racially diverse SMM with HIV. Data were drawn from Thrive With Me (TWM), a randomized controlled trial of an mHealth intervention targeting ART adherence among SMM. Generalized estimating equations (GEEs) models examined longitudinal associations, including between‐ and within‐person effects, between resilience scores and self‐reported 30‐day ART adherence, dichotomized as optimal (≥ 90% of doses) versus suboptimal (< 90% of doses) across the 17‐month study timeframe, while controlling for covariates. Among 401 SMM with HIV that completed the TWM baseline assessment ( M age = 39.1 years, Standard Deviation = 10.8), 59.9% self‐identified as Black/African American. In GEE models, resilience scores were prospectively associated with optimal 30‐day ART adherence ( b = 0.06, β = 0.38, p < 0.001), at the between‐person level, above the effects of covariates. In moderation analyses, resilience scores were associated with optimal ART adherence among Black/African American SMM but not among those identifying as White or another race. These results suggest bolstering resilience may be an important strategy for future interventions aiming to improve ART adherence over time for racially and ethnically diverse SMM with HIV.Keywords
Funding Information
- National Institute on Drug Abuse (R01 DA039950)
- National Institute on Drug Abuse (T32 DA023356)
- National Institute on Drug Abuse (K01 DA055983)
- National Institute on Drug Abuse (F31 DA059345)
This publication has 32 references indexed in Scilit:
- Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literatureClinical Psychology Review, 2017
- A community-engaged randomized controlled trial of an integrative intervention with HIV-positive, methamphetamine-using men who have sex with menBMC Public Health, 2016
- Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analysesBMJ Open, 2016
- Validation of Six Short and Ultra-short Screening Instruments for Depression for People Living with HIV in Ontario: Results from the Ontario HIV Treatment Network Cohort StudyPLOS ONE, 2015
- On disaggregating between-person and within-person effects with longitudinal data using multilevel models.Psychological Methods, 2015
- Feasibility, Acceptability and Preliminary Efficacy of an Online Peer-to-Peer Social Support ART Adherence InterventionAIDS and Behavior, 2013
- HIV Stigma Mechanisms and Well-Being Among PLWH: A Test of the HIV Stigma FrameworkAIDS and Behavior, 2013
- The use of GEE for analyzing longitudinal binomial data: A primer using data from a tobacco interventionAddictive Behaviors, 2007
- New Developments in Biological Measures of Drug Prevalence1997
- Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).1994